text_1: Drug May Delay Pancreatic Cancer Return
text_2: The story describes using an existing chemotherapy drug after surgery to try to delay pancreatic cancer from returning. The story does a nice job of meeting the criteria, including desribing the type of evidence for the latest findings, reporting absolute benefits (including a discussion of the modest cancer-free survival gains), availability and novelty of the drug, cost information, and use of an independent source (and disclosure of study funding sources). And all of this was done in just 688 words.